NANOG and gastric cancer: To further confirm whether a cisplatin resistance caused by the NANOG-TRPV1-pEGFR axis was conserved in NANOGhigh lung or gastric cancer cells, we first tried to select NANOGhgih lung or gastric cancer cell lines, respectively.